Ethiopia EFDA Serialization and Traceability Compliance

Discover OneScan

Global Regulations

Icon graphic element
Labelling

Products are required to display information in writing.

Graphic element
Unit Level Traceability

Sellable units are uniquely identified enabling a more granular traceability.

Graphic element
Aggregation

The packaging hierarchy of products is required to be identified and documented.

Graphic element
Central repository

The traceability documentation is required to be centralized in a unique system.

Summary

Pharmaceutical products in Ethiopia are regulated by the Ethiopian Food and Drug Authority (EFDA) under the Food and Medicine Administration Proclamation No. 1112/2019. Ethiopia has introduced regulatory requirements to improve medicine traceability and combat counterfeit pharmaceutical products.

The EFDA requires pharmaceutical manufacturers and importers to implement serialization using GS1 compliant DataMatrix barcodes on medicine packaging. The system enables verification of medicines and supports supply chain monitoring from manufacturers and importers through distribution.

The Ethiopian traceability framework is designed to align with global GS1 identification standards and supports electronic verification of medicines throughout the supply chain. Serialization requirements apply primarily to human prescription medicines and selected priority pharmaceutical products.

Labelling Requirements 

Medicines marketed in Ethiopia must include a 2D DataMatrix barcode on the secondary packaging to support serialization and traceability.

The DataMatrix must follow GS1 standards and include the following data elements:

  • GTIN
  • Serial Number
  • Batch Number
  • Expiry Date

These elements enable unique identification of each pharmaceutical package and support product verification within the Ethiopian supply chain.

Human readable information printed on the packaging must match the encoded barcode data.

Regulatory Timeline 

  • 2011–2017 – Ethiopia introduced regulatory initiatives aimed at improving pharmaceutical supply chain integrity and combating counterfeit medicines.
  • 2019 – The Ethiopian government adopted Proclamation No. 1112/2019, strengthening the authority of EFDA to regulate medicines and medical products.
  • 2020 onward – EFDA began implementing serialization initiatives and encouraging pharmaceutical manufacturers to adopt GS1 based DataMatrix identification for medicine packages.
  • Current Status – Serialization requirements are being progressively adopted to improve product verification and supply chain oversight.

Reporting Requirements 

Operation
Data to Maintain
When to Record
Serialization
GTIN, Serial Number, Batch, Expiry
During packaging
Import Documentation
Product identification and batch details
Before import approval
Distribution Records
Product identifiers and shipment documentation
During supply chain transfers
Verification
Serialized pack identification
At distribution or dispensing stages
Decommission
Product identifiers and removal reason
When products are destroyed or withdrawn

Companies must maintain accurate traceability records and provide them to EFDA during regulatory inspections when required.

Operational Timelines for Industry 

  • Configure packaging operations to generate serialized identifiers using GS1 standards.
  • Print DataMatrix barcodes containing serialized data on secondary packaging.
  • Maintain traceability records for manufactured and imported pharmaceutical products.
  • Ensure accurate documentation of product movement within the supply chain.
  • Provide traceability data during EFDA inspections when requested.

Reporting Hub

  • Ethiopia’s pharmaceutical traceability system is overseen by the Ethiopian Food and Drug Authority (EFDA).
  • The system supports verification of serialized products through digital identification and authentication mechanisms. Pharmaceutical manufacturers and importers must ensure that serialized identifiers are generated according to EFDA requirements and maintained within their internal traceability systems.
  • While the EFDA regulates serialization requirements, supply chain reporting primarily relies on company traceability systems and regulatory inspections, rather than a centralized national reporting platform.

Aggregation Requirements 

  • Ethiopia's serialization framework focuses on unit level identification using DataMatrix barcodes.
  • Aggregation at case or pallet level is not currently mandated in EFDA guidance. Pharmaceutical companies may implement aggregation internally to improve logistics and warehouse management.

Common Errors to Avoid 

  • Incorrect formatting of GS1 DataMatrix barcodes.
  • Mismatch between serialized barcode data and printed packaging information.
  • Failure to maintain traceability records for serialized products.
  • Incomplete documentation of product movement across the distribution network.

Trusted by Industry Leaders

Smooth and Successful

LSPedia didn’t just provide software; they ensured we were fully compliant. Anytime we had questions, the LSPedia team knew DSCSA inside and out and guided us step by step. That level of expertise made a huge difference during audits. Thanks to their expert team our audit was smooth and successful

Hussein Salman
Lead Pharmacist, Pioneer Pharmacy Services

Constant Commitment

LSPedia shows a constant commitment to improvement; whether it's their support or their product...they're always leveling up. The support team provides consistently thorough follow-up and clear, articulate communication. the support we receive represents a meaningful step up in service and is genuinely appreciated.

Zac Sweeny
EPCIS Data Encoder,Capital Wholesale Drug
Read All TestimonialsView Our Customers

Fill in the form for latest updates

Get in Touch

We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.

Contact Us